TY - JOUR
T1 - Nosocomial BK Polyomavirus Infection Causing Hemorrhagic Cystitis Among Patients With Hematological Malignancies After Hematopoietic Stem Cell Transplantation
AU - Kato, J.
AU - Mori, T.
AU - Suzuki, T.
AU - Ito, M.
AU - Li, T. C.
AU - Sakurai, M.
AU - Yamane, Y.
AU - Yamazaki, R.
AU - Koda, Y.
AU - Toyama, T.
AU - Hasegawa, N.
AU - Okamoto, S.
N1 - Publisher Copyright:
© 2017 The American Society of Transplantation and the American Society of Transplant Surgeons
PY - 2017/9
Y1 - 2017/9
N2 - BK polyomavirus (BKPyV) is recognized as a pathogen that causes diseases such as hemorrhagic cystitis and nephritis after allogeneic hematopoietic stem cell transplantation (HSCT) or renal transplantation. BKPyV-associated disease is thought to occur through reactivation under immunosuppression. However, the possibility of its nosocomial transmission and the clinical significance of such transmission have not been elucidated. During a 6-month period, nine adult patients (median age: 47 years) who had hematological disorders and who were treated with HSCT (n = 7) or chemotherapy (n = 2) in a single hematology department developed hemorrhagic cystitis due to BKPyV infection. The polymerase chain reaction products of BKPyV DNA obtained from each patient were sequenced. Of the nine patients, six had subtype I, 2 had subtype IV, and 1 had subtype II or III. In the alignment of sequences, four and two of the six subtype I strains were completely homologous (100%). These results strongly suggest that BKPyV has the potential to cause nosocomial infection within a medical facility, especially among recipients of HSCT. Further studies are clearly warranted to elucidate the route(s) of BKPyV transmission in order to establish optimal infection control.
AB - BK polyomavirus (BKPyV) is recognized as a pathogen that causes diseases such as hemorrhagic cystitis and nephritis after allogeneic hematopoietic stem cell transplantation (HSCT) or renal transplantation. BKPyV-associated disease is thought to occur through reactivation under immunosuppression. However, the possibility of its nosocomial transmission and the clinical significance of such transmission have not been elucidated. During a 6-month period, nine adult patients (median age: 47 years) who had hematological disorders and who were treated with HSCT (n = 7) or chemotherapy (n = 2) in a single hematology department developed hemorrhagic cystitis due to BKPyV infection. The polymerase chain reaction products of BKPyV DNA obtained from each patient were sequenced. Of the nine patients, six had subtype I, 2 had subtype IV, and 1 had subtype II or III. In the alignment of sequences, four and two of the six subtype I strains were completely homologous (100%). These results strongly suggest that BKPyV has the potential to cause nosocomial infection within a medical facility, especially among recipients of HSCT. Further studies are clearly warranted to elucidate the route(s) of BKPyV transmission in order to establish optimal infection control.
KW - clinical research/practice
KW - infection and infectious agents
KW - infection and infectious agents
KW - infectious disease
KW - viral: BK/JC/polyoma
UR - http://www.scopus.com/inward/record.url?scp=85018631096&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85018631096&partnerID=8YFLogxK
U2 - 10.1111/ajt.14271
DO - 10.1111/ajt.14271
M3 - Article
C2 - 28295968
AN - SCOPUS:85018631096
SN - 1600-6135
VL - 17
SP - 2428
EP - 2433
JO - American Journal of Transplantation
JF - American Journal of Transplantation
IS - 9
ER -